To enlarge the scope of COVID-19 diagnostic tests that may be used for the issuance of an EU Digital COVID Certificate, the definition of rapid antigen tests set out in Article 2, point 5, of Regulation (EU) 2021/953 was amended by Regulation (EU) 2022/1034 to include laboratory-based antigenic assays. It is now possible for Member States to issue test certificates and, following the adoption of Commission Delegated Regulation (EU) 2022/256 [Commission Delegated Regulation (EU) 2022/256 of 22 February 2022 amending Regulation (EU) 2021/953 of the European Parliament and of the Council as regards the issuance of certificates of recovery based on rapid antigen tests (OJ L 42, 23.2.2022, p. 4).], certificates of recovery on the basis of the antigen tests included in the EU common list of COVID-19 antigen tests, as agreed, and regularly updated, by the Health Security Committee and as meeting the established criteria.
Recital 4, Decision_act (EU) 2022/1516
In forcesince 8 Sep 2022
- celex=32021R0953
- num:eu=2021/953